celecoxib has been researched along with glucosamine in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 22 (66.67) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bingham, CO; Bradley, JD; Brandt, KD; Clegg, DO; Cush, JJ; Furst, DE; Harris, CL; Hooper, MM; Jackson, CG; Klein, MA; Lane, NE; Molitor, JA; Moreland, LW; Moskowitz, RW; O'Dell, JR; Oddis, CV; Reda, DJ; Sawitzke, AD; Schnitzer, TJ; Schumacher, HR; Shi, H; Weisman, MH; Williams, HJ; Wolfe, F; Yocum, DE | 1 |
| Traynor, K | 1 |
| Clegg, DO; Hochberg, MC | 1 |
| Brizuela, NY; Demurtas, SL; Meirovich, CI; Montrull, HL | 1 |
| Bingham, CO; Bradley, JD; Clegg, DO; Dunlop, DD; Finco, MF; Furst, DE; Harris, CL; Jackson, CG; Lane, NE; Lisse, J; Moskowitz, RW; Oddis, CV; Reda, DJ; Sawitzke, AD; Shi, H; Silver, D; Singer, NG; Williams, HJ; Wolfe, F | 1 |
| Kvien, TK; Olsen, IC; Uhlig, T | 1 |
| Bichile, L; Chopra, A; Handa, R; Joshi, K; Narsimulu, G; Patwardhan, B; Raut, A; Saluja, M; Sarmukkaddam, S; Sumantran, V; Tillu, G; Venugopalan, A | 1 |
| Dieppe, P; Marsden, D | 1 |
| Doschak, MR; Fallone, BG; Jaremko, JL; Lambert, RG; Maksymowych, WP; Panahifar, A; Tessier, AG | 1 |
| Arden, N; Berenbaum, F; Blanco, FJ; Castillo, JR; Conaghan, PG; Doménech, G; du Souich, P; Henrotin, Y; Hochberg, MC; Martel-Pelletier, J; Möller, I; Monfort, J; Pap, T; Pelletier, JP; Richette, P; Sawitzke, A | 1 |
| Onuora, S | 1 |
| Meyer, R | 1 |
| Lei, GH; Wei, J; Zeng, C | 1 |
| Danilov, AB; Grigorenko, NV | 1 |
| Gao, SG; Lei, GH; Li, H; Li, YS; Luo, W; Wang, YL; Wei, J; Xie, DX; Yang, T; Zeng, C | 1 |
| Shaughnessy, AF | 1 |
| Plate, A | 1 |
| Marcus, DM | 1 |
| Reginster, JL | 1 |
| Lee, YH | 1 |
| Reginster, JY | 1 |
| Choi, MS; Chung, MJ; Elfadl, AK; Ghim, SG; Goo, MJ; Hong, IH; Jeon, SM; Jeong, DH; Jeong, KS; Kim, AY; Kim, JH; Kim, SY; Kim, YD; Lee, EJ; Ullah, HMA | 1 |
| Gu, Y; Han, Z; Li, P; Tang, L; Tao, J; Zhang, Q; Zhang, W | 1 |
| Azzolina, D; Barbetta, B; Giacovelli, G; Gregori, D; Gualtieri, F; Minto, C; Rovati, LC; Vaghi, P | 1 |
| Herrero, M; Ladd, J; Lampe, JW; Lampe, PD; Lo, E; Martinez, H; Navarro, SL; Randolph, TW; Shelley, D; Zhang, Y | 1 |
| Ge, R; Yang, Z; Zhang, J | 1 |
| Cheleschi, S; Ecarnot, F; Fioravanti, A; Maggi, S; Veronese, N | 1 |
| Barbarino, M; Bottaro, M; Carta, S; Cheleschi, S; Collodel, G; Corsaro, R; Fioravanti, A; Moretti, E; Veronese, N | 1 |
4 review(s) available for celecoxib and glucosamine
| Article | Year |
|---|---|
[An antinociceptive effect of chondroprotectors: a myth or a reality?].
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Celecoxib; Chondroitin Sulfates; Chronic Pain; Cyclooxygenase 2 Inhibitors; Cytokines; Drug Combinations; Glucosamine; Humans; Interleukin-10; Interleukin-6; Low Back Pain; Nociceptive Pain; Osteoarthritis; Randomized Controlled Trials as Topic; Syndrome | 2015 |
Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee.
Topics: Arthralgia; Celecoxib; Chondroitin; Drug Therapy, Combination; Glucosamine; Humans; Odds Ratio; Osteoarthritis, Knee; Pain Management; Treatment Outcome | 2015 |
Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
Topics: Adrenal Cortex Hormones; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Celecoxib; Female; Follow-Up Studies; Glucosamine; Humans; Injections, Intra-Articular; Male; Middle Aged; Osteoarthritis, Knee; Pain Management | 2018 |
Possible synergic action of non-steroidal anti-inflammatory drugs and glucosamine sulfate for the treatment of knee osteoarthritis: a scoping review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Glucosamine; Humans; Observational Studies as Topic; Osteoarthritis, Knee; Pain; Randomized Controlled Trials as Topic | 2022 |
8 trial(s) available for celecoxib and glucosamine
| Article | Year |
|---|---|
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin Sulfates; Double-Blind Method; Drug Therapy, Combination; Female; Glucosamine; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Pyrazoles; Severity of Illness Index; Sulfonamides; Treatment Outcome | 2006 |
Potential effects of chondroitin sulfate on joint swelling: a GAIT report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin Sulfates; Double-Blind Method; Female; Glucosamine; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pyrazoles; Radiography; Sulfonamides; Treatment Outcome | 2008 |
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT.
Topics: Aged; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Drug Combinations; Female; Glucosamine; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Radiography; Sulfonamides; Treatment Outcome | 2010 |
Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial.
Topics: Aged; Analysis of Variance; Celecoxib; Confidence Intervals; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Glucosamine; Humans; India; Male; Medicine, Ayurvedic; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Patient Selection; Plant Extracts; Pyrazoles; Range of Motion, Articular; Recovery of Function; Risk Assessment; Severity of Illness Index; Sulfonamides; Tinospora; Treatment Outcome; Zingiber officinale | 2013 |
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.
Topics: Aged; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Combinations; Edema; Female; Glucosamine; Humans; Male; Middle Aged; Musculoskeletal Pain; Osteoarthritis, Knee; Pain Measurement; Quality of Life; Treatment Outcome | 2016 |
[Not Available].
Topics: Aged; Celecoxib; Chondroitin Sulfates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucosamine; Humans; Male; Middle Aged; Osteoarthritis, Knee | 2016 |
Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients.
Topics: Aged; Anti-Inflammatory Agents; Biomarkers; Celecoxib; Chemokine CCL20; Chondroitin; Colony-Stimulating Factors; Down-Regulation; Drug Therapy, Combination; Female; Glucosamine; Humans; Interleukin-6; Male; Middle Aged; Osteoarthritis; Wnt Proteins | 2020 |
Effect of celecoxib combined with glucosamine hydrochloride in promoting the functional recovery and decreasing the inflammatory factor levels in patients with knee osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Protein; Celecoxib; Female; Glucosamine; Humans; Immunoglobulin M; Inflammation; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Recovery of Function; Rheumatoid Factor; Serum Albumin; Serum Globulins; Tumor Necrosis Factor-alpha | 2021 |
21 other study(ies) available for celecoxib and glucosamine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Glucosamine & chondroitin use questioned in mild cases. Drug combo benefits moderate-to-severe knee osteoarthritis, but not so with lesser cases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin; Dietary Supplements; Glucosamine; Humans; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Placebo Effect; Pyrazoles; Sulfonamides | 2006 |
Arthritis supplement combination falls short in study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin Sulfates; Clinical Trials as Topic; Dietary Supplements; Glucosamine; Humans; Osteoarthritis; Pain; Pyrazoles; Sulfonamides; Treatment Outcome | 2006 |
[Articular cartilage in osteoarthritic patients: effects of diclofenac, celecoxib and glucosamine sulfate on inflammatory markers].
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cartilage, Articular; Celecoxib; Chondrocytes; Cyclooxygenase Inhibitors; Diclofenac; Enzyme-Linked Immunosorbent Assay; Glucosamine; Humans; Matrix Metalloproteinases; Nitric Oxide; Osteoarthritis; Pyrazoles; Sulfonamides | 2007 |
The NIH Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT).
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chondroitin Sulfates; Clinical Trials as Topic; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Glucosamine; Humans; Male; Middle Aged; National Institutes of Health (U.S.); Osteoarthritis, Knee; Pain; Pyrazoles; Sulfonamides; Treatment Outcome; United States | 2008 |
Consequences of handling missing data for treatment response in osteoarthritis: a simulation study.
Topics: Bias; Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Data Interpretation, Statistical; Glucosamine; Humans; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Randomized Controlled Trials as Topic; Research Design; Sulfonamides; Treatment Outcome | 2012 |
Managing arthritis: the need to think about whole systems.
Topics: Celecoxib; Female; Glucosamine; Humans; Male; Medicine, Ayurvedic; Osteoarthritis, Knee; Plant Extracts; Pyrazoles; Sulfonamides | 2013 |
Development and reliability of a multi-modality scoring system for evaluation of disease progression in pre-clinical models of osteoarthritis: celecoxib may possess disease-modifying properties.
Topics: Animals; Anterior Cruciate Ligament; Bone Cysts; Bone Marrow Diseases; Cartilage, Articular; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Disease Progression; Glucosamine; Knee Injuries; Magnetic Resonance Imaging; Osteoarthritis, Knee; Osteophyte; Pyrazoles; Rats; Reproducibility of Results; Severity of Illness Index; Sulfonamides; Synovitis; X-Ray Microtomography | 2014 |
Clinical trials: Glucosamine-chondroitin combo improves knee OA pain.
Topics: Celecoxib; Chondroitin Sulfates; Cyclooxygenase 2 Inhibitors; Edema; Female; Glucosamine; Humans; Male; Osteoarthritis, Knee | 2015 |
Does MOVES move the needle?
Topics: Celecoxib; Chondroitin; Drug Therapy, Combination; Glucosamine; Humans; Multicenter Studies as Topic; Osteoarthritis, Knee; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome | 2015 |
Is chondroitin sulfate plus glucosamine superior to placebo in the treatment of knee osteoarthritis?
Topics: Celecoxib; Chondroitin; Drug Therapy, Combination; Glucosamine; Humans; Multicenter Studies as Topic; Osteoarthritis, Knee; Placebo Effect; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides | 2015 |
Chondroitin/Glucosamine Equal to Celecoxib for Knee Osteoarthritis.
Topics: Arthralgia; Celecoxib; Chondroitin; Cyclooxygenase 2 Inhibitors; Drug Combinations; Education, Medical, Continuing; Glucosamine; Humans; Osteoarthritis, Knee | 2016 |
Chondroitin sulfate for knee osteoarthritis.
Topics: Celecoxib; Chondroitin Sulfates; Glucosamine; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
CONCEPT provides robust evidence that chondroitin sulfate is superior to placebo and similar to celecoxib in the symptomatic management of osteoarthritis.
Topics: Celecoxib; Chondroitin Sulfates; Glucosamine; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
Chondroitin sulfate is superior to placebo in symptomatic knee osteoarthritis.
Topics: Celecoxib; Chondroitin Sulfates; Double-Blind Method; Glucosamine; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
Differentiation between various Chondroitin sulfate formulations in symptomatic knee osteoarthritis.
Topics: Celecoxib; Chondroitin Sulfates; Glucosamine; Humans; Osteoarthritis, Knee; Pharmaceutical Preparations | 2018 |
Effects of oral glucosamine hydrochloride and mucopolysaccharide protein in a rabbit model of osteoarthritis.
Topics: Administration, Oral; Animals; Anterior Cruciate Ligament; Apoptosis; Cartilage, Articular; Celecoxib; Chondrocytes; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Glucosamine; Glycosaminoglycans; Hindlimb; Joints; Osteoarthritis; Rabbits; Time Factors | 2018 |
A novel near-infrared fluorescent probe for monitoring cyclooxygenase-2 in inflammation and tumor.
Topics: Animals; Carbocyanines; Celecoxib; Cyclooxygenase 2; Female; Fluorescent Dyes; Glucosamine; HCT116 Cells; Hep G2 Cells; Humans; Infrared Rays; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Conformation; Solubility; Water | 2018 |
MicroRNA as Possible Mediators of the Synergistic Effect of Celecoxib and Glucosamine Sulfate in Human Osteoarthritic Chondrocyte Exposed to IL-1β.
Topics: Apoptosis; Celecoxib; Cells, Cultured; Chondrocytes; Glucosamine; Humans; Interleukin-1beta; MicroRNAs; NF-kappa B; Reactive Oxygen Species | 2023 |